1. Erkin A, Kosemehmetoglu K, Diler MS, Koksal C. Evaluation of the minimum effective concentration of the sclerosant in an ex-vivo study. Eur J Vasc Endovasc Surg. 2012;44(6):593–7.
2. Ikpommwosa A, Abbot C, Graham A, et al. The impact of different concentrations of sodium tetradecyl sulphate and initial balloon denudation on endothelial cell loss and tunica media injury in a model of foam sclero therapy. Eur J Vasc Endovasc Surg. 2010;39(3):366–71.
3. Drake LA, Dinehart SM, Goltz RW, et al. Guidelines of care of sclerotherapy treatment of varicose veins and telangiectatic leg veins. J Am Acad Dermatol. 1996;34:523–8.
4. Rabe E, Pannier-Fischer F, Gerlach H, et al. Guidelines for sclerotherapy of varicose veins. Dermatol Surg. 2004;30:687–93.
5. Hamel-Desnos C, Ourvy P, Benigni JP, et al. Comparison of 1 % and 3 % polidocanol foam in ultrasound guided sclerotherapy of great saphenous vein: a randomized double blind trial with two year follow up. The 3/1 study’. Eur J Vasc Endovasc Surg. 2007;34:723–9.